Vertex Pharmaceuticals (VRTX) Gross Profit Growth (5y) (2015 - 2026)
Vertex Pharmaceuticals (VRTX) Gross Profit Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.11% |
| Dec 31, 2025 | 13.84% |
| Sep 30, 2025 | 14.51% |
| Jun 30, 2025 | 13.80% |
| Mar 31, 2025 | 12.22% |
| Dec 31, 2024 | 144.40% |
| Sep 30, 2024 | 23.81% |
| Jun 30, 2024 | 23.06% |
| Mar 31, 2024 | 25.20% |
| Dec 31, 2023 | 23.51% |
| Sep 30, 2023 | 26.31% |
| Jun 30, 2023 | 27.52% |
| Mar 31, 2023 | 29.93% |
| Dec 31, 2022 | 28.90% |
| Sep 30, 2022 | 32.26% |
| Jun 30, 2022 | 32.54% |
| Mar 31, 2022 | 22.63% |
| Dec 31, 2021 | 35.54% |
| Sep 30, 2021 | 37.43% |
| Jun 30, 2021 | 32.63% |